Masses are one of the early signs of breast cancer, and the survival rate of women suffering from breast cancer can be improved if masses can be correctly identified as benign or malignant. However, their classification is challenging due to the similarity in texture patterns of both types of mass. The existing methods for this problem have low sensitivity and specificity. Based on the hypothesis that diverse contextual information of a mass region forms a strong indicator for discriminating benign and malignant masses and the idea of the ensemble classifier, we introduce a computer-aided system for this problem. The system uses multiple regions of interest (ROIs) encompassing a mass region for modeling diverse contextual information, a sin...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...
Prompt diagnosis of benign and malignant breast masses is essential for early breast cancer screenin...
The paper presents quantitative results of a preliminary study undertaken as part of Decision Suppor...
Abstract Breast cancer is the second deadliest cancer among women. Mammography is an important metho...
We are currently experiencing a revolution in data production and artificial intelligence (AI) appli...
Abstract A computer-aided diagnosis (CAD) system requires automated stages of tumor detection, segme...
Background: breast cancer (BC) is the world’s most prevalent cancer in the female population, with 2...
Medical diagnosis sometimes involves detecting subtle indications of a disease or condition amongst ...
This work proposes a new approach using a committee machine of artificial neural networks to classif...
Breast cancer (BC) is currently the most common form of cancer diagnosed worldwide with an incidence...
© 2020 IEEE. This study presents pre-trained Convolutional Neural Network (CNN) models to classify p...
Mammography is the most effective and available tool for breast cancer screening. However, the low p...
We present an integrated methodology for detecting, segmenting and classifying breast masses from ma...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...
Prompt diagnosis of benign and malignant breast masses is essential for early breast cancer screenin...
The paper presents quantitative results of a preliminary study undertaken as part of Decision Suppor...
Abstract Breast cancer is the second deadliest cancer among women. Mammography is an important metho...
We are currently experiencing a revolution in data production and artificial intelligence (AI) appli...
Abstract A computer-aided diagnosis (CAD) system requires automated stages of tumor detection, segme...
Background: breast cancer (BC) is the world’s most prevalent cancer in the female population, with 2...
Medical diagnosis sometimes involves detecting subtle indications of a disease or condition amongst ...
This work proposes a new approach using a committee machine of artificial neural networks to classif...
Breast cancer (BC) is currently the most common form of cancer diagnosed worldwide with an incidence...
© 2020 IEEE. This study presents pre-trained Convolutional Neural Network (CNN) models to classify p...
Mammography is the most effective and available tool for breast cancer screening. However, the low p...
We present an integrated methodology for detecting, segmenting and classifying breast masses from ma...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer is the most frequent disease in women, with one in every 19 women at risk. Breast canc...
Breast cancer accounts for 30% of all female cancers. Accurately distinguishing dangerous malignant ...